ESMO Revises Early Prostate Cancer Diagnosis and Monitoring

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse. Medscape News UK

Read the full article on medscape.com